REDUCTION OF SPUTUM PSEUDOMONAS-AERUGINOSA DENSITY BY ANTIBIOTICS IMPROVES LUNG-FUNCTION IN CYSTIC-FIBROSIS MORE THAN DO BRONCHODILATORS AND CHEST PHYSIOTHERAPY ALONE

被引：225

作者：

REGELMANN, WE ^{[1
]}

ELLIOTT, GR ^{[1
]}

WARWICK, WJ ^{[1
]}

CLAWSON, CC ^{[1
]}

机构：

[1] UNIV MINNESOTA,DEPT PEDIAT,MINNEAPOLIS,MN 55455

来源：

AMERICAN REVIEW OF RESPIRATORY DISEASE | 1990年 / 141卷 / 04期

关键词：

D O I：

10.1164/ajrccm/141.4_Pt_1.914

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：914 / 921

页数：8

共 28 条

[1]

[Anonymous], 1971, STAT PRINCIPLES EXPT

[2] IS ANTI-PSEUDOMONAS THERAPY WARRANTED IN ACUTE RESPIRATORY EXACERBATIONS IN CHILDREN WITH CYSTIC-FIBROSIS [J].

BEAUDRY, PH ;

MARKS, MI ;

MCDOUGALL, D ;

DESMOND, K ;

RANGEL, R .

JOURNAL OF PEDIATRICS, 1980, 97 (01) :144-147

[3]

BRASFIELD D, 1979, PEDIATRICS, V63, P24

[4]

EDBERG SC, 1986, ANTIBIOTICS LABORATO, P381

[5]

GIBSON LE, 1959, PEDIATRICS, V23, P545

[6] CONTROLLED TRIAL OF CEFTAZIDIME VS TICARCILLIN AND TOBRAMYCIN IN THE TREATMENT OF ACUTE RESPIRATORY EXACERBATIONS IN PATIENTS WITH CYSTIC-FIBROSIS [J].

GOLD, R ;

OVERMEYER, A ;

KNIE, B ;

FLEMING, PC ;

LEVISON, H .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1985, 4 (02) :172-177

[7] RANDOMIZED TRIAL OF CEFTAZIDIME VERSUS PLACEBO IN THE MANAGEMENT OF ACUTE RESPIRATORY EXACERBATIONS IN PATIENTS WITH CYSTIC-FIBROSIS [J].

GOLD, R ;

CARPENTER, S ;

HEURTER, H ;

COREY, M ;

LEVISON, H .

JOURNAL OF PEDIATRICS, 1987, 111 (06) :907-913

[8]

Hansen L, 1967, Minn Med, V50, P1191

[9] PHARMACOKINETICS OF TOBRAMYCIN IN PATIENTS WITH CYSTIC-FIBROSIS - IMPLICATIONS FOR THE DOSING INTERVAL [J].

HORREVORTS, AM ;

DEGENER, JE ;

DZOLJICDANILOVIC, G ;

MICHEL, MF ;

KERREBIJN, KF ;

DRIESSEN, O ;

HERMANS, J .

CHEST, 1985, 88 (02) :260-264

[10]

HORREVORTS AM, 1987, CHEST, V920, P844

← 1 2 3 →